Internal Medicine Doctors in Wharton, TX Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Nadim Syed Jafri, M.D.,M.SC. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700

Dr. Robin Lynn Ferguson, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2112 Regional Medical Dr Ste 1317, Wharton, TX 77488 Phone: 979-245-2008    Fax: 979-314-7164

Dr. Carlos D. Zorrilla, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700    Fax: 979-532-6726

Dr. Kimberly Vogel Coonfield, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700    Fax: 979-532-4584

Dr. Fernando Antonio Salazar, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700    Fax: 979-532-6726

Dr. Henry J. Lopez-roman, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2100 Regional Medical Dr, Wharton, TX 77488 Phone: 979-532-1700    Fax: 979-532-6754

News Archive

Montreux invests $30 million in GCAL

Montreux Equity Partners, LLC, and GC Aesthetics, Ltd., today announced the completion of a US$30 million private equity investment by Montreux into GCAL. GCAL is a leading designer, manufacturer, and distributor of medical devices for the global aesthetics industry. Montreux entered into the financing agreement with GCAL to accelerate the company's expansion plans.

Neuroscientists discover specific brain circuit that triggers cocaine relapse in mice

Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.

Compliance leaders give insight and thoughts in new ebook

Regulatory non compliance costs the pharma industry billions in fines, audits and much more each year. To avoid these fines and bad reputation pharma companies rely heavily on their compliance teams, who provide oversight from R&D to the very end of a product cycle.

Penn study provides new insight into cause of peripartum cardiomyopathy in pregnant women

Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months following delivery. But the cause of peripartum cardiomyopathy has been largely unknown - until now.

Read more Medical News

› Verified 3 days ago